ArticleJournal of advanced pharmaceutical technology & research2011
Pharmacognostic parameters for evaluation of the rhizomes of Curcuma caesia.
Article in Journal of advanced pharmaceutical technology & research, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
9 citing papers in PubMed.
- Chemometric-guided diversity study of black turmeric essential oils from Eastern India revealed industrially feasible quality chemotypes with promising bioactivities.Scientific reports · 2025Article
- Article
- A Comprehensive Review with Future Prospects on the Medicinal Properties and Biological Activities ofEvidence-based complementary and alternative medicine : eCAM · 2023Review
- Article
- Antioxidant and antimutagenic activity ofToxicology reports · 2015Article
- Antioxidant potential of hydro-methanolic extract of seed of Caesalpinia bonduc: An in vitro study.Journal of advanced pharmaceutical technology & research · 2011Article
- Comparative Physicochemical Evaluation of Kharekhasak (Pharmacognosy researchArticle
- Standardization of Unani Antidiabetic Tablet - Qurse Tabasheer.Pharmacognosy researchArticle
- Methanolic Extract of Curcuma caesia Roxb. Prevents the Toxicity Caused by Cyclophosphamide to Bone Marrow Cells, Liver and Kidney of Mice.Pharmacognosy researchArticle
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
In ethno medicinal practices, the traditional healers use the genus Curcuma for the treatment of various ailments but Curcuma caesia Roxb. is a very less known and almost untouched drug. The present work attempts to establish the necessary pharmocognostic standards for evaluating the plant material of C. caesia Roxb. Various parameters, such as morphology, microscopy, physicochemical constants, and phytochemical profiles of the entire parts of the plant were studied and the salient diagnostic features are documented. Major chemical constituents, extractive values, physicochemical constants, and other features are also been recorded.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.